Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis

NCT01285700 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha Mannosidosis

Interventions

DRUG: Lamazym

Sponsor

Zymenex A/S

Collaborators

[object Object]